glp-1 inhibitor Agonists what is a glp-1 inhibitor
Description
Ditzenberger GL, Lake JE, Kitch DW, Kantor A, Muthupillai R, Moser C, et al
Obesity induces metabolic disturbances in adipose tissue, influencing the release of hormones, adipokines, inflammatory cytokines, growth factors, enzymes, and free fatty acids [12]
The documentation your insurer typically wants includes a recorded BMI meeting the threshold (30 or above, or 27 with comorbidities), proof of at least one qualifying comorbidity, evidence of previous weight loss attempts (usually 3-6 months of documented lifestyle intervention), current lab work showing relevant metabolic markers, and a letter of medical necessity from your prescribing physician
Weight Loss Potential: Modest results, typically between 2 to 10 pounds
Forbes: Trump Administration Says it Wants More OTC Meds But So Far No Action What do you think
2021;106(2):E592-601
